2009 Chemical and Biological Terrorism Defense Gordon Research Conference
2009 Chemical and Biological Terrorism Defense Gordon Research Conference
批准号:
7608881
负责人:
MOLLY A HUGHES
金额:
$1.5万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-15 至 2009-11-30
关键词:
AcuteAddressAllergicAnimalsAreaBiologicalBioterrorismChemical AgentsChemicalsDetectionDiagnosticEnhancersEnvironmental HazardsEventGoalsHealthImmuneImmune responseImmunomodulatorsInterventionMagicMedicalMedicineOralParticipantPharmaceutical PreparationsPopulationProcessPublic HealthReadinessRequest for ProposalsResearchResearch PersonnelScreening procedureSystemTechnologyTerrorismTherapeuticTranslational ResearchUnited StatesVaccinesmeetingsnovel strategiespostersprogramssymposium
中文摘要
描述(由申请人提供):本提案要求部分支持2009年化学和生物恐怖主义防御戈登研究会议,将在加尔维斯顿,德克萨斯州,2009年1月18日至23日举行。2009年的主题体现了会议的广泛和长期目标,即将“日常”与“也许有一天”相结合。在开发防御措施,特别是医学对策或检测系统以应对生物或化学威胁方面存在许多挑战。本次会议将重点讨论一系列主题,其中新的研究集中在广谱和平台技术方法上,以发现和开发生物和化学威胁的防御措施,这些措施既利用又整合了“日常”应用。这次会议的具体目标是召集总共135名与会者,其中预计将有54人发言,代表新的关键研究领域,这些领域是在新办法方面实现“飞跃”所必需的,以便将防范化学或生物恐怖主义对健康的影响与医药、公共卫生、严重的环境危害。该计划将有一个主题演讲会议和八个科学会议,涉及广谱治疗,诊断平台技术,将化学和生物检测整合到通用平台中;早期宿主对生物和化学制剂的反应;转化研究:动物到人类;“魔术子弹”:免疫调节剂和免疫增强剂;生物和化学制剂的“OMICS”;以及筛选策略:干预的目标和机会。除了口头介绍外,还将提供大量的海报展示机会。这一应用程序的意义在于,戈登研究会议化学和生物恐怖主义准备提供了一个独特的机会,在这个有点“利基”领域的过敏过程研究人员之间的密切互动和研究信息交流。这种应用的健康相关性是,化学和生物恐怖主义防御研究的最终目标是为健康干预提供新的机会,无论是药物,疫苗,诊断还是检测系统,以帮助保护美国人口在恐怖主义袭击事件中使用这些代理。
英文摘要
DESCRIPTION (provided by applicant): This proposal requests partial support for the 2009 Chemical and Biological Terrorism Defense Gordon Research Conference, to be held in Galveston, TX, January 18 - 23, 2009. The broad and long term goal of the conference, as embodied in the theme for 2009, is Integrating "Everyday" with "Maybe Someday". There are numerous challenges in developing defenses, particularly medical countermeasures, or detection systems, to address biological or chemical threats. This Conference will focus on an array of topics in which new research has been focused on broad spectrum and platform technology approaches to discovering and developing defenses for biological and chemical threats that both leverage and integrate "everyday" applications. The specific aims of this meeting will be to convene a total of 135 participants, of which it is anticipated that 54 will be speakers, to represent new and critical areas of research that will be needed to allow the "leap ahead" in new approaches to integrating preparedness for the health impacts of chemical or biological terrorism with "everyday" technologies and systems for medicine, public health, and acute environmental hazards. The program will have a keynote address session and eight scientific sessions that address broad spectrum therapeutics, platform technologies for diagnostics, integration of chemical and biological detection into general use platforms; early host responses to biological and chemical agents; translational research: animals to people; "magic bullets": immunomodulators and immune enhancers; "OMICS" for biological and chemical agents; and screening strategies: targets and opportunities for intervention. In addition to the oral presentations, ample opportunities for poster sessions will be provided. The significance of this application is that the Gordon Research Conference on Chemical and Biological Terrorism Preparedness provides a unique opportunity for close interaction and exchange of research information among allergic process researchers in this somewhat "niche" area. The health relatedness of this application is that the ultimate goal of research in chemical and biological terrorism defense is to provide new opportunities for health interventions, whether they be drugs, vaccines, diagnostics, or detection systems, to help protect the population of the United States in the event of a terrorism attack with these agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
-
批准号:10468194
-
项目类别:
-
资助金额:$60.65万
-
财政年份:2020
-
负责人:MOLLY A HUGHES
-
依托单位:
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
-
批准号:10676878
-
项目类别:
-
资助金额:$61.31万
-
财政年份:2020
-
负责人:MOLLY A HUGHES
-
依托单位:
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
-
批准号:10120102
-
项目类别:
-
资助金额:$59.88万
-
财政年份:2020
-
负责人:MOLLY A HUGHES
-
依托单位:
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
-
批准号:10269939
-
项目类别:
-
资助金额:$63.1万
-
财政年份:2020
-
负责人:MOLLY A HUGHES
-
依托单位:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
-
批准号:8646871
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2013
-
负责人:MOLLY A HUGHES
-
依托单位:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
-
批准号:8822201
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2013
-
负责人:MOLLY A HUGHES
-
依托单位:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
-
批准号:8435665
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2013
-
负责人:MOLLY A HUGHES
-
依托单位:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
-
批准号:9029273
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2013
-
负责人:MOLLY A HUGHES
-
依托单位:
2011 Chemical & Biological Terrorism Defense Gordon Research Conference (GRC) and
-
批准号:8052353
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2010
-
负责人:MOLLY A HUGHES
-
依托单位:
Innate Immune Recognition of B. anthracis
-
批准号:7530781
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2008
-
负责人:MOLLY A HUGHES
-
依托单位:
Innate Immune Recognition of B. anthracis
-
批准号:7633403
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2008
-
负责人:MOLLY A HUGHES
-
依托单位:
Studies on Macrophage Resistance to Anthrax Lethal Toxin
-
批准号:6804467
-
项目类别:
-
资助金额:$26.62万
-
财政年份:2003
-
负责人:MOLLY A HUGHES
-
依托单位:
Studies on Macrophage Resistance to Anthrax Lethal Toxin
-
批准号:6676407
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2003
-
负责人:MOLLY A HUGHES
-
依托单位:
Identification of E. histolytica virulence factors
-
批准号:6423015
-
项目类别:
-
资助金额:$12.22万
-
财政年份:2002
-
负责人:MOLLY A HUGHES
-
依托单位:
Identification of E. histolytica virulence factors
-
批准号:6770139
-
项目类别:
-
资助金额:$12.22万
-
财政年份:2002
-
负责人:MOLLY A HUGHES
-
依托单位:
Identification of E. histolytica virulence factors
-
批准号:6603149
-
项目类别:
-
资助金额:$12.22万
-
财政年份:2002
-
负责人:MOLLY A HUGHES
-
依托单位:
海外基金